Damora Therapeutics, Inc. (DMRA)
30.62
+0.31
(+1.02%)
USD |
NASDAQ |
Aug 25, 16:00
30.74
+0.12
(+0.39%)
After-Hours: 19:59
Damora Therapeutics Total Assets (Quarterly) : 543.64M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 543.64M |
| March 31, 2026 | 535.44M |
| December 31, 2025 | 260.53M |
| September 30, 2025 | 10.74M |
| June 30, 2025 | 13.69M |
| March 31, 2025 | 15.36M |
| December 31, 2024 | 17.13M |
| September 30, 2024 | 23.38M |
| June 30, 2024 | 27.30M |
| March 31, 2024 | 32.48M |
| December 31, 2023 | 38.23M |
| September 30, 2023 | 50.05M |
| Date | Value |
|---|---|
| June 30, 2023 | 58.80M |
| March 31, 2023 | 64.63M |
| December 31, 2022 | 73.19M |
| September 30, 2022 | 82.02M |
| June 30, 2022 | 92.86M |
| March 31, 2022 | 108.93M |
| December 31, 2021 | 122.22M |
| September 30, 2021 | 135.87M |
| June 30, 2021 | 146.82M |
| March 31, 2021 | 158.66M |
| December 31, 2020 | 171.60M |
| September 30, 2020 | 98.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.58M |
| Shareholders Equity (Quarterly) | 516.06M |
| Current Ratio | 19.73 |
| Net Debt Paydown Yield | 0.02% |